Clinical Trials Browser

INDUSTRY × Abiraterone Acetate × Tumor-Agnostic × Clear all

NCT01650194 2024-12-10

A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

Phase 2 Completed

60 enrolled 24 charts

Neoplasms